Case Reports
Journal Article
Add like
Add dislike
Add to saved papers

Macrocystic serous cystadenoma mimicking branch duct intraductal papillary mucinous neoplasm.

A 29-year-old woman was referred to our hospital with a pancreatic cystic tumor diagnosed by computed tomography and magnetic resonance imaging. Endoscopic retrograde cholangiopancreatography was performed, wherein macrocystic serous cystadenoma of the pancreas was diagnosed. It was decided to observe the progress of the disease. The tumor diameter increased over 18 months to > 50 mm. Its growth rate was slower than the average rate of serous cystadenoma described in previous reports, but its form become warped and shaped like bunches of grapes. A branch duct variant of intraductal papillary mucinous neoplasm could not be excluded. Laparoscope-assisted distal pancreatectomy was performed, and the pathological diagnosis was macrocystic serous cystadenoma. Some macrocystic serous cystadenomas are like an intraductal papillary mucinous neoplasm, and differential diagnosis is very difficult. The macrocystic serous cystadenoma is a rare lesion, but it should be considered when diagnosing cystic tumors of the pancreas.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app